Загрузка...
Harnessing gemcitabine metabolism: a step towards personalized medicine for pancreatic cancer
Pancreatic cancer is a lethal malignancy with a 5-year survival rate of only 6%. Surgical resection remains the only cure, yet even after resection the 5-year survival is only 20% due to a high recurrence rate. Thus, a high proportion of patients with this disease will ultimately require systemic ch...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3481558/ https://ncbi.nlm.nih.gov/pubmed/23118809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834012453755 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|